pf-04802540
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00756743)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
GRM1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-04802540
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00876304 | Phase 1 | Apr 1, 2009 | Pfizer, Taisho Pharmaceutical |
| NCT00772512 | Phase 1 | Nov 1, 2008 | Pfizer, Taisho Pharmaceutical |
| NCT00756743 | Phase 1 | Sep 1, 2008 | Pfizer, Taisho Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 3 | 0 | 1 | 2008 |
| Taisho Pharmaceutical | For profit | 3 | 3 | 1 | 2008 |
2 organizations
Page 1 / 1